Bulletin
Investor Alert

CRISPR Therapeutics AG

NAS: CRSP

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201181046/composite

$

62.50

Change

-0.11 -0.18%

Volume

Volume 178,151

Jan 21, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201181046/composite

Previous close

$ 64.36

$ 62.61

Change

-1.75 -2.72%

Day low

Day high

$62.21

$66.42

Open
Open: 63.72

52 week low

52 week high

$62.21

$191.10

Open

Market cap

$4.79B

Average volume

1.60M

P/E ratio

13.15

Rev. per Employee

$2.20M

EPS

4.76

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crsp

MarketWatch News on CRSP

  1. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  2. Beam Gets FDA Nod for First Gene-Editing Trial

    8:10 a.m. Nov. 9, 2021

    - Barron's Online

  3. Prime Is the Newest Gene Editing, and It's Getting Better

    6:11 p.m. Oct. 20, 2021

    - Barron's Online

  4. Crispr Therapeutics stock price target cut to $101 from $139 at Stifel Nicolaus

    5:44 a.m. Oct. 13, 2021

    - Tomi Kilgore

  5. This Fund Is Winning Big by Betting on Stocks That Help Humanity

    6:37 a.m. Sept. 27, 2021

    - Barron's Online

  6. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    8:21 a.m. June 30, 2021

    - Barron's Online

  7. First In-Vivo Gene Editing Data Look Good for Intellia

    7:40 a.m. June 28, 2021

    - Barron's Online

  8. Vertex Shares Fall as Drug Fails. Analysts Say It's Time to Buy.

    7:37 a.m. June 11, 2021

    - Barron's Online

  9. How a Cloud Is Lifting from Bluebird and Other Gene Therapy Stocks

    12:38 p.m. June 7, 2021

    - Barron's Online

  10. 5 Undervalued Stocks in Biopharma, the Sweet Spot in Healthcare

    4:40 p.m. April 21, 2021

    - Barron's Online

  11. Crispr Therapeutics Is Upgraded After $900 Million Deal

    9:33 p.m. April 21, 2021

    - Barron's Online

  12. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/crsp

Other News on CRSP

  1. Brave Asset Management Inc Buys iShares Core U.S. ...

    4:38 p.m. Jan. 21, 2022

    - GuruFocus.com

  2. It's Time To Go To Cash For The Next 7 Years - 1-Year Update

    2:41 p.m. Jan. 20, 2022

    - Seeking Alpha

  3. Editas (EDIT) Focuses on Developing Gene-Editing Eye Drug

    10:46 a.m. Jan. 19, 2022

    - Zacks.com

  4. 11 Good And 4 Bad Reasons To Keep Holding ARK Invest

    3:42 p.m. Jan. 18, 2022

    - Seeking Alpha

  5. Crispr Therapeutics: Tons Of Upside From Current Prices

    8:13 a.m. Jan. 18, 2022

    - Seeking Alpha

  6. Is Beam Therapeutics a Good Stock to Buy Now?

    6:47 a.m. Jan. 16, 2022

    - Motley Fool

  7. 4 Biotech Acquisitions We'd Like to See in 2022

    6:10 a.m. Jan. 14, 2022

    - Motley Fool

  8. Crispr Therapeutics' Giant Leap For Humankind

    4:39 a.m. Jan. 14, 2022

    - Seeking Alpha

  9. 3 No-Brainer Big Pharma Stocks to Buy in 2022

    9:27 a.m. Jan. 9, 2022

    - Motley Fool

  10. "Motley Fool Money" 2022 Investing Preview

    2:00 p.m. Jan. 7, 2022

    - Motley Fool

  11. Loading more headlines...
/news/pressrelease/company/us/crsp

Press Releases on CRSP

  1. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.